Episode Summary
Executive Summary: George Zachary of CRV reflects on 25+ years in venture, arguing that great investing is driven by human conviction, not market-size models or charisma. He explains how macro cycles taught him valuation discipline, why venture is a returns business, how he backs founders who need to build, and how personal health shaped his move into bioengineering. He also discusses board philosophy, generational transition, and his changing relationship with money.
Main Topics: Entry into venture and lessons from macro cycles (Priority: 5/5): George recounts entering venture in 1995 after a startup-heavy career and says the dot-com and 2008 busts made him more cautious about overheated valuations and capital-intensive companies. Human-led conviction in founders (Priority: 5/5): He says his strongest skill is sensing founder energy, intelligence, and force of will directly from conversations, rather than relying on market reports or data rooms. Returns business vs. investing business (Priority: 5/5): George argues LPs pay VCs for returns, not for writing checks, and criticizes large funds and fee-driven incentives that can distort decision-making. Founder psychology and the need to build (Priority: 4/5): He believes exceptional founders often have a psychological need to master chaos, sometimes rooted in early instability, which drives repeated company-building. Board philosophy and founder relationship management (Priority: 4/5): George describes good boards as supportive but non-intrusive, emphasizing 'nose in, hands out' and tailoring involvement to whether he is an early or later investor. Pivot to bioengineering and health investing (Priority: 5/5): A personal cancer scare and desire to improve health access pushed him toward bioengineering, where he partnered with scientific operators to compensate for his own domain gaps. Money, status, and trust (Priority: 4/5): He candidly shares that wealth changed how others treated him, created trust issues, and made him more selective about relationships and social circles.
Key Arguments: Macro bubbles teach discipline: seeing 2000 and 2008 made him wary of euphoria, valuation excess, and financing companies that need too many rounds. The best founders are not necessarily charismatic; they have force of will, coherence, and the sense that they want investors out of the way. VCs should optimize for returns, not number of investments or total dollars deployed; fee dependence can weaken alignment. Market size is often a narrative tool, not a truth; new markets can look small until a founder creates them. He backs people who need to build big companies, not just want to, because that motivation sustains long-term persistence. Great board members support founders emotionally and strategically, but avoid meddling unless asked. Transition at VC firms requires younger partners and acceptance that older investors may miss new paradigms. Wealth changes social dynamics and can isolate people because others may become transactional.
Data Points: Venture entry year: 1995 - George says he entered venture after earlier startup work when someone recruited him into the business. Years in venture: 21+ years - Harry introduces George as having an incredible multi-decade career in the venture industry. CRV tenure: 16 years - George has spent 16 years at CRV leading investments in companies like PillPack and Udacity. Prior firm tenure: 6+ years - He previously served as a general partner at Mohr Davidow Ventures for more than six years. Investment exposure before PillPack: $240 million - George says that up to that point in his career, over roughly 22-23 years, he had invested about this amount. PillPack check size: $30 million - He describes writing a very large check into PillPack from a $300-400 million fund. Time to commit to PillPack: 4 days - George says by day four after meeting TJ Parker, he was ready to write the check. Yammer follow-on conviction: Series A during 2008-09 financial crisis - He doubled down when Genie pivoted to Yammer despite the macro downturn. Original seed deal size (historical context): $300,000 - George notes that when he started, seed rounds were roughly this size and looked very different from today’s. Typical Series A valuation example: $20 million to $100 million - He contrasts a standard Series A valuation from three years earlier with a quintupled valuation during frothy periods. Fund-size example: $500 million - He uses this as an example of why a $30 million exit may not meaningfully move a large VC fund. Twitter original team size: 5 people - George says there were five people involved at the beginning of Twitter. Total number of venture entrants in 1995-96: ~50 people - He says about 50 people entered venture in 1995-96, but only a handful remained years later. Venture survivors from that cohort: ~5 people - George says only about five of that cohort were still left in the business several years ago. Most recent public investment: Glimpse - He names Glimpse, a bioengineering company in Boston, as his latest publicly announced investment. Carter promotion: 10% off - Sponsor offer for listeners using carter.com/20VC. Brex promotion: $500 credit after spending $1,000 - Sponsor offer tied to the 20VC code and November 30 deadline.
Pivotal Quotes: "I'd rather invest in a great company at a good price versus a good company at a great price." — George Zachary: George explains his valuation discipline and how he frames investment decisions in overheated markets. "We're in the returns business, not the investment business." — George Zachary: He distinguishes true VC value creation from simply deploying capital and criticizes fee-driven fund behavior. "Nose in, hands out." — George Zachary: His shorthand for effective board behavior: stay informed, but do not meddle unless the founder asks for help.
Implications: Listeners get a blueprint for conviction-led venture investing: trust founder psychology, stay disciplined on price, and avoid fee-driven behavior. The episode also signals growing importance of bioengineering and the need for VC firms to refresh talent across generations.